{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:51:51Z","timestamp":1773885111539,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002767","name":"Hunan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2023SK2003"],"award-info":[{"award-number":["2023SK2003"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.conctc.2025.101557","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:26:31Z","timestamp":1760001991000},"page":"101557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy and safety of Chinese medicine compound for the convalescent COVID-19 patients: Protocol of a multi-centered, randomized, double-blinded, placebo-controlled clinical trial"],"prefix":"10.1016","volume":"48","author":[{"given":"Rui","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanyao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shasha","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanmei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunhua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dahua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinwen","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.conctc.2025.101557_bib1","article-title":"Weekly epidemiological update and weekly operational update","year":"2025","journal-title":"World Health Organ."},{"key":"10.1016\/j.conctc.2025.101557_bib2","first-page":"2354","article-title":"Expert consensus on health management during recovery period of COVID-19 infection","volume":"65","author":"Zhang","year":"2022","journal-title":"Health Res."},{"key":"10.1016\/j.conctc.2025.101557_bib3","article-title":"The prevalence and long-term health effects of long covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis","volume":"55","author":"O'Mahoney","year":"2022","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.conctc.2025.101557_bib4","article-title":"COVID-19 and its long-term sequelae: what do we know in 2023?","volume":"133","author":"Lippi","year":"2023","journal-title":"Pol. Arch. Intern. Med."},{"key":"10.1016\/j.conctc.2025.101557_bib5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/23744235.2021.1924397","article-title":"Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments","volume":"53","author":"Yong","year":"2021","journal-title":"Inf. Disp."},{"key":"10.1016\/j.conctc.2025.101557_bib6","first-page":"427","article-title":"Expert consensus on the diagnosis and treatment of long COVID syndrome","volume":"16","year":"2023","journal-title":"Chin. J. Clin. Infect. Dis."},{"key":"10.1016\/j.conctc.2025.101557_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.conctc.2025.101557_bib8","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/eurheartj\/ehac031","article-title":"Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus","volume":"43","author":"Raman","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.conctc.2025.101557_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1001\/jama.2024.11370","article-title":"Evidence mounts that about 7% of US adults have had long COVID","volume":"332","author":"Fang","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.conctc.2025.101557_bib10","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1001\/jama.2022.18931","article-title":"Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021","volume":"328","author":"Hanson","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.conctc.2025.101557_bib11","article-title":"Long COVID facts and findings: a large-scale online survey in 74,075 Chinese participants","volume":"52","author":"Qin","year":"2024","journal-title":"Lancet Reg. Health West. Pac."},{"key":"10.1016\/j.conctc.2025.101557_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.17440","article-title":"Epidemiologic features of recovery from SARS-CoV-2 infection","volume":"7","author":"Oelsner","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.conctc.2025.101557_bib13","series-title":"Final NIH Coronavirus Disease (COVID-19) Treatment Guidelines","year":"2021"},{"key":"10.1016\/j.conctc.2025.101557_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/jama.2023.24103","article-title":"Studies investigate whether antivirals like paxlovid may prevent long COVID","volume":"331","author":"Suran","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.conctc.2025.101557_bib15","first-page":"1","article-title":"Diagnosis and treatment of COVID-19 (10th pilot version)","volume":"20","year":"2023","journal-title":"Chin. J. Ration. Drug Use"},{"key":"10.1016\/j.conctc.2025.101557_bib16","series-title":"Expert guidelines on health management for the convalescent COVID-19 patients (1st edition)","year":"2022"},{"key":"10.1016\/j.conctc.2025.101557_bib17","first-page":"1024","article-title":"Treatment of coronavirus disease 2019 (COVID-19) from perspective of dampness-toxicity plagues","volume":"61","author":"Zheng","year":"2020","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.conctc.2025.101557_bib18","first-page":"2354","article-title":"TONG Xiaolin's cold-damp epidemic differentiation and treatment concepts and diagnostic and therapeutic key points","volume":"64","author":"Xue","year":"2023","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.conctc.2025.101557_bib19","first-page":"4181","article-title":"Clinical study on comprehensive rehabilitation program of traditional Chinese medicine for patients with different syndrome types in Corona virus disease 2019 recovery period","volume":"37","author":"Sun","year":"2022","journal-title":"China J. Tradit. Chin. Med. Pharm."},{"key":"10.1016\/j.conctc.2025.101557_bib20","first-page":"377","article-title":"Discussion of traditional Chinese medicine syndrome and treatment of novel coronavirus pneumonia based on pulmonary spleen-related pathogenesis","volume":"37","author":"Liu","year":"2020","journal-title":"Tianjin J. Tradit. Chin. Med."},{"key":"10.1016\/j.conctc.2025.101557_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/st9.0000000000000007","article-title":"Theory and scientificity of traditional Chinese medicine","volume":"1","author":"Guo","year":"2023","journal-title":"Sci. Traditi. Chin. Med."},{"key":"10.1016\/j.conctc.2025.101557_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153671","article-title":"Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): a single-center, open-label, randomized controlled trial","volume":"91","author":"Liu","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.conctc.2025.101557_bib23","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.scib.2024.04.040","article-title":"Effectiveness and safety of sanhan Huashi granules versus nirmatrelvir-ritonavir in adult patients with COVID-19: a randomized, open-label, multicenter trial","volume":"69","author":"Zou","year":"2024","journal-title":"Sci. Bull. (Beijing)"},{"key":"10.1016\/j.conctc.2025.101557_bib24","first-page":"42","article-title":"Ge Jinwen's experience in the treatment of COVID-19 Omicron infection based on the perspective of cold plague","volume":"39","author":"Yang","year":"2023","journal-title":"Hunan J. Tradit. Chin. Med."},{"key":"10.1016\/j.conctc.2025.101557_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.conctc.2025.101557_bib26","first-page":"186","volume":"vols. 58\u201360","author":"Zheng","year":"2002"},{"key":"10.1016\/j.conctc.2025.101557_bib27","first-page":"86","article-title":"The diagnostic criteria for TCM syndromes of coronavirus disease 2019 (trial edition)","volume":"62","author":"Li","year":"2021","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.conctc.2025.101557_bib28","first-page":"177","article-title":"Diagnostic criteria of TCM syndromes of chronic obstructive pulmonary disease (2011 edition)","volume":"53","year":"2012","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.conctc.2025.101557_bib29","first-page":"1375","article-title":"Interpretation of 2021 ERS\/ATS interpretive strategies for routine lung function tests","volume":"22","author":"Li","year":"2022","journal-title":"Chin. J. Evidence-Based Med."},{"key":"10.1016\/j.conctc.2025.101557_bib30","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/s13063-021-05418-y","article-title":"Baidu Jieduan granules, traditional Chinese medicine, in the treatment of moderate coronavirus disease-2019 (COVID-19): study protocol for an open-label, randomized controlled clinical trial","volume":"22","author":"Zhang","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.conctc.2025.101557_bib31","doi-asserted-by":"crossref","DOI":"10.1177\/20458940211032125","article-title":"Bufei huoxue capsules in the management of convalescent COVID-19 infection: study protocol for a multicenter, double-blind, and randomized controlled trial","volume":"11","author":"Chen","year":"2021","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.conctc.2025.101557_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13020-022-00602-x","article-title":"Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial","volume":"17","author":"An","year":"2022","journal-title":"Chin. Med."},{"key":"10.1016\/j.conctc.2025.101557_bib33","first-page":"649","article-title":"Application of the technology of Serum specific antibody in detecting 2019 novel coronavirus","volume":"11","author":"Ning","year":"2020","journal-title":"Med. J. Peking Union Med. Coll. Hosp."},{"key":"10.1016\/j.conctc.2025.101557_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0022-3999(02)00392-6","article-title":"Psychometric qualities of a brief self-rated fatigue measure: the Fatigue Assessment scale","volume":"54","author":"Michielsen","year":"2003","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.conctc.2025.101557_bib35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-3999(72)90041-4","article-title":"Some relationships between subjective measures of pain","volume":"16","author":"Woodforde","year":"1972","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.conctc.2025.101557_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.conctc.2025.101557_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.conctc.2025.101557_bib38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.conctc.2025.101557_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.990639","article-title":"Chinese medicine for residual symptoms of COVID-19 recovered patients (long COVID)-A double-blind, randomized, and placebo-controlled clinical trial protocol","volume":"9","author":"Sum","year":"2023","journal-title":"Front. Med."},{"issue":"14","key":"10.1016\/j.conctc.2025.101557_bib40","article-title":"Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia","volume":"13","author":"Naik","year":"2024","journal-title":"BMJ Open"},{"issue":"340","key":"10.1016\/j.conctc.2025.101557_bib41","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"23","author":"Moher","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.conctc.2025.101557_bib42","article-title":"Covid-19: Pfizer's paxlovid is 89% effective in patients at risk of serious illness, company reports","volume":"375","author":"Mahase","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.conctc.2025.101557_bib43","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1473-3099(23)00685-0","article-title":"A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial","volume":"24","author":"Lau","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.conctc.2025.101557_bib44","first-page":"43","article-title":"Efficacy and safety of Molnupiravir in the treatment of COVID-19: a meta-analysis","volume":"24","author":"Liang","year":"2024","journal-title":"Chin. J. Evidence-Based Med."},{"key":"10.1016\/j.conctc.2025.101557_bib45","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.conctc.2025.101557_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.765553","article-title":"Honeysuckle (Lonicera japonica) and huangqi (Astragalus membranaceus) suppress SARS-CoV-2 entry and COVID-19 related cytokine storm in vitro","volume":"12","author":"Yeh","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.conctc.2025.101557_bib47","doi-asserted-by":"crossref","first-page":"11821","DOI":"10.1039\/D0RA07035A","article-title":"The inhibition of Mpro, the primary protease of COVID-19, by Poria cocos and its active compounds: a network pharmacology and molecular docking study","volume":"11","author":"Wu","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.conctc.2025.101557_bib48","first-page":"13","article-title":"Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP","volume":"45","author":"Ma","year":"2020","journal-title":"China J. Chin. Mater. Med."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865425001310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865425001310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:23:40Z","timestamp":1773865420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865425001310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":48,"alternative-id":["S2451865425001310"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2025.101557","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of Chinese medicine compound for the convalescent COVID-19 patients: Protocol of a multi-centered, randomized, double-blinded, placebo-controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2025.101557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101557"}}